Late filing
elevated
Filing comparison
Addex Therapeutics Ltd. told the SEC it could not file its annual report on time
Addex Therapeutics Ltd (the “Company”) was unable to file its Annual Report on Form 20-F for the year ended December 31, 2025 (the “Form 20-F”) without unreasonable effort or expense by the due date because of a delay experienced by the Company in completing its financial statements and other disclosures in the Form 20-F. The Company currently anticipates the Form 20-F will be filed as soon as practicable on or before the 15th calendar day following the prescribed due date.
Evidence
- Days past due date
- 30
- Routine
- No
- Severity
- elevated
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- Addex Therapeutics Ltd (the “Company”) was unable to file its Annual Report on Form 20-F for the year ended December 31, 2025 (the “Form 20-F”) without unreasonable effort or expense by the due date because of a delay experienced by the Company in completing its financial statements and other disclosures in the Form 20-F. The Company currently anticipates the Form 20-F will be filed as soon as practicable on or before the 15th calendar day following the prescribed due date.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.